Red Light Therapy
What is it: Red or near-infrared light treatment aimed at supporting cellular energy and reducing inflammation.AKA: Cold Laser Therapy, LLLT, Low-Intensity Light Therapy, Low-Level Laser Therapy, PBM, Photobiomodulation- ⬤ Minimal research: Very little scientific study exists, with no or very few peer-reviewed studies. Insufficient data for conclusions.
- ⬤⬤ Limited research: Few studies exist, mostly small trials or case reports. Findings are preliminary and lack strong validation.
- ⬤⬤⬤ Moderately researched: Multiple studies, including mid-sized trials, exist. Some findings are replicated, but more research is needed.
- ⬤⬤⬤⬤ Well-researched: Supported by substantial evidence, including at least one large trial or meta-analysis.
- ⬤⬤⬤⬤⬤ Extensively studied: Numerous large studies and meta-analyses exist. Findings are widely accepted with strong scientific consensus.
- ⬤ Extremely Difficult to Access: Rare, experimental, or highly specialized. Requires multiple referrals, long wait times, travel, and strict follow-up.
- ⬤⬤ Difficult to Access: Limited to select centers with moderate barriers. Requires referral, potential travel, and wait times of weeks to months.
- ⬤⬤⬤ Moderately Accessible: Available in larger hospitals or clinics. Requires a basic referral, with moderate wait times and some coordination.
- ⬤⬤⬤⬤ Easy to Access: Widely available in most clinics. Minimal referral, short wait times, and simple preparation or follow-up.
- ⬤⬤⬤⬤⬤ Trivial to Access: Easily found in pharmacies or clinics. No referral needed, minimal wait, and straightforward access.
- ⬤ Up to $100
- ⬤⬤ Up to $500
- ⬤⬤⬤ Up to $2000
- ⬤⬤⬤⬤ Up to $10,000
- ⬤⬤⬤⬤⬤ More than $10,000
To calculate the reported effectiveness for a patient view, the model first analyses whether it can be ascertained that the person writing the review has had direct experience of the treatment for themselves or a loved one. If so, it then uses sentiment analysis to rate their view from 1-5 on how effective this treatment was for them, with 1 being the least effective, and 5 the most effective.
12 Resources
Referenced in this guide
45 Research papers
Referenced in this guide
12 Expert views
Contributed in this guide
41 Patient views
Contributed in this guide
Figure out what Red Light Therapy means for you
Page contents
Basics: What you need to know
Transcranial Photobiomodulation Therapy (tPBMT) applies targeted red light (often between 630 nm and 670 nm) to stimulate the mitochondria inside brain cells, potentially aiding individuals with neurodegenerative conditions. By improving energy production, mitigating oxidative stress, and enhancing neuronal health, this approach aims to support overall brain function for those grappling with Parkinson’s Disease. tPBMT stands out from casual at-home red light devices due to its clinically tested standards in dosages and application methods, designed explicitly to address neurological challenges. Although research is ongoing, preliminary results show promise in easing some symptoms and offering a potential therapy to slow disease progression.
History and development
- Early groundwork: Initial studies on photobiomodulation in the late 1960s and 1970s piqued interest in how low-level light influences cellular behavior. Researchers noted enhanced tissue repair and reduced inflammation.
- Refined protocols: Over time, experts like Dr. Michael R. Hamblin refined the technology, developing standardized treatments and wavelengths aimed at treating brain-related disorders.
- Neuro-focused trials: In the 2010s, international research groups began applying red light therapy transcranially for neurological conditions, including Parkinson’s Disease, systematically establishing safety and dosage guidelines.
What is known
- Mitochondrial support: The red light wavelengths used in tPBMT challenge oxidative stress and promote ATP production, which fuels cells and may enhance neuronal resilience.
- Possible motor benefits: Clinical observations suggest some improvements in motor functions, such as balance and reduced tremors, though the extent varies across studies.
- Secondary effects: There’s evidence this therapy might help with mood regulation, cognitive function, and overall quality of life, possibly through increased neuroplasticity.
- Safety profile: As a non-invasive approach, tPBMT typically has mild side effects when used correctly, making it suitable for repeated use in clinical settings.
What is not known
- Long-term impact: Although short-to-medium-term data are encouraging, more studies are needed to confirm how tPBMT affects disease progression over many years.
- Optimal parameters: Researchers continue to refine the precise wavelength, dosage, and treatment duration needed to maximize benefits and minimize any risks.
- Patient variability: Not all patients respond in the same way; the reasons for these differences are still not fully understood.
- Worsening of symptoms: While rare, certain individuals may experience headaches or discomfort from light exposure, but whether tPBMT can exacerbate Parkinsonian symptoms in some people is not definitively established.
- Targeted wavelength: Strictly defined red light (630–670 nm) reaches the brain through the skull.
- Cellular energizing: Light absorption by mitochondria increases ATP production, supporting cell function.
- Reduced oxidative stress: Key reactive oxygen species are lowered, decreasing cellular damage.
- Enhanced circulation: Improved blood flow may accelerate nutrient delivery to affected brain regions.
- Neuroprotective response: Boosted energy reserves and reduced inflammation help guard neurons.
- Mild headaches: Occasionally reported after treatment sessions.
- Light sensitivity: Some experience discomfort or strain from bright LEDs.
- Rare skin irritation: Prolonged exposure may cause slight redness on the scalp.
- Uncertain long-term data: Some experts argue there isn’t enough proof of decade-long effects.
- Variability in response: Differences in individual physiology lead to mixed clinical results.
- Protocol gaps: Critics highlight a lack of consensus on treatment frequency and duration.
- Equipment inconsistencies: Some believe standardization across devices is not yet fully achieved.
Patient views
Experiences
- Patients appreciate improved sleep and reduced tremors.
- Many find it helpful for energy and mood.
- Some report better gut health and reduced inflammation.
- It is seen as promising for motor and non-motor symptoms.
Challenges
- Devices are expensive, costing up to $1600.
- Time-consuming daily use is challenging for some.
- Results can be inconsistent or slow to appear.
- Some report no noticeable improvement in symptoms.
Tips
- Research devices and choose FDA-approved options.
- Combine therapy with exercise and healthy habits.
- Be patient; results may take months.
- Consider clinical trials for cost-effective access.
To calculate the reported effectiveness for a patient view, the model first analyses whether it can be ascertained that the person writing the review has had direct experience of the treatment for themselves or a loved one. If so, it then uses sentiment analysis to rate their view from 1-5 on how effective this treatment was for them, with 1 being the least effective, and 5 the most effective.
Patient view
Red light therapy has helped a lot for that.
August 2024 • Turnto Comment
Patient view
redlightsonthebrain.blog, written by retired doctor Catherine Hamilton in Tasmania (who created a red light helmet) has lots of valuable information on red light therapy and its health benefits. 😊
September 2024 • Turnto Comment
Expert views
What they liked
- Experts appreciate its potential to improve motor and non-motor symptoms.
- Studies show benefits for sleep, mood, and fatigue in Parkinson's patients.
- It may enhance brain cell energy and reduce inflammation.
- Non-invasive and relatively safe compared to other treatments.
What they didn't like
- High cost of devices like light arrays and helmets.
- Effectiveness depends on skull thickness and light penetration.
- Limited evidence for long-term benefits in humans.
- Some experts worry about misleading marketing claims.
What are they unsure about
- Experts are uncertain about optimal timing and duration of therapy.
- Questions remain about its ability to penetrate the brain effectively.
- Lack of consensus on whether it works better for specific symptoms.
- More research needed to confirm its impact on disease progression.
12 expert views
Expert view
Dr. Wayne Markman discussed the potential of red light therapy for Parkinson's disease, referencing research from the University of Sydney. In studies, mice with Parkinson's symptoms showed significant improvements in movement, balance, and motivation after being treated with infrared light. However, when the vagus nerve, which connects the gut and brain, was severed, the therapy no longer worked. This suggests a strong connection between the gut and brain in Parkinson's disease. Dr. Markman emphasized that this research is well-documented and published in scientific journals.
July 2024 • Q & A with Sharon's son, George Episode 35 Special Guest Wayne Markman Symbyx
Expert view
Dr. Virgilio Gerald H. Evidente discussed the use of phototherapy, also known as light therapy, for Parkinson's disease. He explained that this therapy was compared to a placebo and involved using a specialized device called the Celeste phototherapy device for one hour each evening over six months. The therapy aims to regulate the circadian rhythm, which is often disrupted in Parkinson's patients, leading to sleep issues. Dr. Evidente noted that phototherapy improved both motor and non-motor symptoms of Parkinson's disease.
December 2021 • MDFA Webinar - May 14 2021
What and who it targets
Patients with fatigue
Improves energy and reduces fatigue symptoms.
Early-stage patients
Potential for neuroprotection and symptom management.
Cognitive decline sufferers
May support cognitive function improvement.
Relevant research
How much evidence on this?
- Over 10 studies, including animal and human trials.
- Research spans at least a decade, starting from 2015.
- Studies include randomized controlled trials and pilot studies.
- Evidence from both motor and non-motor symptom improvements.
Research focusing on
- Improves motor symptoms like gait and balance.
- Safe with minimal side effects like dizziness.
- Effective in both transcranial and remote applications.
- Researchers exploring long-term effects and optimal dosages.
What needs more research?
- Mechanisms of action, especially systemic effects, unclear.
- Long-term safety and efficacy in large populations unknown.
- Optimal light parameters (wavelength, intensity) not standardized.
- Effectiveness compared to standard treatments unclear.
- ⬤ Minimal research: Very little scientific study exists, with no or very few peer-reviewed studies. Insufficient data for conclusions.
- ⬤⬤ Limited research: Few studies exist, mostly small trials or case reports. Findings are preliminary and lack strong validation.
- ⬤⬤⬤ Moderately researched: Multiple studies, including mid-sized trials, exist. Some findings are replicated, but more research is needed.
- ⬤⬤⬤⬤ Well-researched: Supported by substantial evidence, including at least one large trial or meta-analysis.
- ⬤⬤⬤⬤⬤ Extensively studied: Numerous large studies and meta-analyses exist. Findings are widely accepted with strong scientific consensus.
Research
This paper analyzed multiple studies to evaluate how effective and safe light therapy (LT) is for treating both motor and non-motor symptoms in people with Parkinson's disease. Researchers reviewed randomized controlled trials from several databases and used statistical tools to assess the quality and reliability of the evidence.
The meta-analysis found that light therapy significantly improved motor function, with patients showing better scores compared to those exposed to dim-red light. Non-motor symptoms like depression and sleep disturbances also improved, with measurable benefits in mood and sleep quality after light therapy.
For someone living with Parkinson's, this study suggests that light therapy could be a promising non-drug option to help manage both movement difficulties and emotional or sleep-related challenges. It offers hope for improving daily life without relying solely on medications.
This paper is highly reliable as it is a meta-analysis, which combines data from multiple randomized controlled trials, considered the gold standard in research. It was published in a reputable journal, ensuring the findings are well-supported and relevant to the field.
January 2022 • Medical science monitor : international medical journal of experimental and clinical research
Research
This study explored the effects of polychromatic light therapy on Parkinson's disease symptoms, comparing it to red light therapy and discontinuation of light therapy. Patients were assessed using various scales and questionnaires before and after a two-week trial period.
Patients who continued polychromatic light therapy showed significant improvements in motor symptoms, sleep quality, and overall well-being, as measured by standardized scales. In contrast, those exposed to red light therapy or who discontinued light therapy experienced deterioration in symptoms.
For individuals with Parkinson's, this study suggests that polychromatic light therapy could be a promising option to improve motor and secondary symptoms, including sleep and mood. It highlights the potential role of light therapy in managing the disease beyond traditional dopamine replacement treatments.
The study is a controlled clinical trial published in a reputable journal, 'Frontiers in Neurology,' which adds credibility. However, further research is needed to confirm these findings and explore the mechanisms involved.
February 2019 • Frontiers in neurology
Accessibility
- ⬤ Extremely Difficult to Access: Rare, experimental, or highly specialized. Requires multiple referrals, long wait times, travel, and strict follow-up.
- ⬤⬤ Difficult to Access: Limited to select centers with moderate barriers. Requires referral, potential travel, and wait times of weeks to months.
- ⬤⬤⬤ Moderately Accessible: Available in larger hospitals or clinics. Requires a basic referral, with moderate wait times and some coordination.
- ⬤⬤⬤⬤ Easy to Access: Widely available in most clinics. Minimal referral, short wait times, and simple preparation or follow-up.
- ⬤⬤⬤⬤⬤ Trivial to Access: Easily found in pharmacies or clinics. No referral needed, minimal wait, and straightforward access.
- ⬤ Up to $100
- ⬤⬤ Up to $500
- ⬤⬤⬤ Up to $2000
- ⬤⬤⬤⬤ Up to $10,000
- ⬤⬤⬤⬤⬤ More than $10,000
Method to access
- Purchase devices like the SYMBYX Neuro helmet online for at-home use.
- Some clinics offer sessions, typically requiring direct booking.
- Clinical trials may provide access to therapy under supervision.
Cost
- At-home devices like the SYMBYX Neuro helmet cost approximately €990.
- Clinic sessions range from $25 to $150 per session.
- Advanced laser treatments can cost $1,445–$2,509.
Insurance cover
- Insurance coverage varies; some plans may cover therapy for medical reasons like pain relief.
- Medicare offers limited coverage for medically necessary light therapy.
- Coverage often requires a formal diagnosis and prescription.
Locations
- SYMBYX Neuro helmet available online with international shipping.
- Clinics in Laguna Niguel, CA, and other locations offer sessions.
- Clinical trials are ongoing in Australia and other regions.
Frequently asked questions
Key resources
More lists
Explore other treatments
It's a lot of information, isn't it?
Turnto's personal AI Assistant can help you figure out what this all means for you
© 2026 Turnto
